Replies to post #205432 on Biotech Values

[Titan V]

The fact a new subsidiary, Zolovax, has been created for this endeavor leads me to believe that it will be spun out in the near future and Heat Biologics could be sold for its cancer immunotherapy pipeline. HTBX has 4 data readouts this quarter:

Heat Biologics Remains on Track to Achieve Multiple Topline Data Readouts this Quarter
http://ir.heatbio.com/press-releases/detail/534/heat-biologics-remains-on-track-to-achieve-multiple

They have not hired a replacement CFO since early 2016. If HTBX were planning to stay independent till phase 3, one would assume they would have a CFO in place. Just my opinion of course.

Some articles on Heat's platform being applied outside of cancer immunotherapy:
http://www.vaccinenation.org/2013/03/20/research-success-siv-lead-hiv-vaccine/
http://www.npccs.com/news/item/nih-awards-grant-to-advance-testing-of-heat-biologics-immunotherapy-vaccine-to-treat-hiv
http://med.miami.edu/news/hope-for-hiv-vaccine-found-in-miller-school-researchers-siv-vaccine-study

[Titan V]

Scientists are bewildered by Zika's path across Latin America
http://wapo.st/2e81y78